Our Company has undergone several transformative milestones so far.

We keep pushing the envelope and re-invent ourselves when needed, in order to remain an innovative, dynamic and hyper-focused enterprise.

Scroll down to discover our milestones.

Cannovex receives R&D license from Dutch Office for Medicinal Cannabis

3rd December 2019

Cannovex has been awarded an offical R&D License for its facility in the Netherlands. Here it can now legally cultivate cannabis plants for research and development purposes.

Cannovex Secures Series A Financing

1st June 2019

Cannovex succesfully completes series A financing round, raising a total of 5 million euros to fund the formulation and development of the first cannabinoid-based medicines.

Rendocan is renamed Cannovex

18th March 2019

The company Rendocan bvba officially changes its name to Cannovex. “Cannovex” is also an officially registered trademark.

Partnership with Brightlands Campus Greenport Venlo

4th March 2019

Cannovex BV (NL) signs a partnership with Brightlands Campus Greenport in Venlo and puts op office at the Villa Flora.

Company Receives Building Permit (BE)

1st March 2019

Rendocan bvba formally receives the building permit to establish a 6.200 m² research and development facility at Agropolis-Kinrooi.

Cannovex BV (The Netherlands) is founded

26th February 2019

Cannovex BV is founded as the Dutch subsidiary of Cannovex Holding BV (NL).
Rendocan bvba is 100% owner of Cannovex Holding BV (NL).

Endorsement of University of Maastricht and Province of Limburg (NL)

28th January 2019

The company receives official endorsement of its plans to research and develop Cannabinoid-Based Medicine  in the Netherlands’ Province of Limburg.

Company HQ in Bioville

4th March 2017

Rendocan bvba establishes its headquarters at the LRM bio-science and healthcare incubator “Bioville” at the University Campus in Diepenbeek (Belgium).

Partnership with UHasselt

1st November 2016

The Company signs a letter of intent with the University of Hasselt to conduct scientific research on cannabis and cannabinoids for medical purposes and the development of medicine.

Partnership with Agropolis-Kinrooi Business Park

10th June 2016

The company signs strategic partnership with Agropolis-Kinrooi Business Park and requires exclusive rights on the cultivation of cannabis plants on the 40 hectare site.

Company Established

3rd June 2016

Company founded under the name “Rendocan bvba”
by Joris Vanvinckenroye and Steven Peters.

Our Partners

Cannovex BV

Agoralaan Abis
3590 Diepenbeek

cannovex web 2

© 2020 – Cannovex BV – All rights reserved

Tel: +32 11 28 69 00